Sylvia Cheung Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sylvia Cheung.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sylvia Cheung. Sylvia Cheung is Chief Financial Officer in Anika Therapeutics, Inc. ($ANIK).
Latest Insider Trading Transactions of Sylvia Cheung
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,700 | 0 | 11,700 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 42.25 | 881 | 37,222 | 49,281 | 50.2 K to 49.3 K (-1.76 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 3,000 | 0 | 50,162 | 47.2 K to 50.2 K (+6.36 %) |
| Feb 06 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 40.59 | 579 | 23,502 | 47,162 | 47.7 K to 47.2 K (-1.21 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.36 | 35,000 | 222,600 | 0 | |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 59.71 | 20,000 | 1,194,200 | 47,741 | 67.7 K to 47.7 K (-29.52 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 60.48 | 3,681 | 222,627 | 67,741 | 71.4 K to 67.7 K (-5.15 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 6.36 | 35,000 | 222,600 | 71,422 | 36.4 K to 71.4 K (+96.10 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 61.47 | 7,609 | 467,725 | 7,609 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 38.10 | 607 | 23,127 | 36,422 | 37 K to 36.4 K (-1.64 %) |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 37.97 | 579 | 21,985 | 37,029 | 37.6 K to 37 K (-1.54 %) |
| Mar 02 2018 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 50.13 | 7,788 | 390,412 | 7,788 | |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 61.47 | 21,400 | 1,315,458 | 21,400 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.99 | 807 | 5,641 | 0 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.99 | 4,193 | 29,309 | 20,000 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 10.99 | 5,000 | 54,950 | 0 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.02 | 807 | 39,559 | 37,608 | 38.4 K to 37.6 K (-2.10 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.05 | 1,193 | 58,517 | 38,415 | 39.6 K to 38.4 K (-3.01 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 6.99 | 5,000 | 34,950 | 39,608 | 34.6 K to 39.6 K (+14.45 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.01 | 2,000 | 98,020 | 34,608 | 36.6 K to 34.6 K (-5.46 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 49.20 | 1,117 | 54,956 | 36,608 | 37.7 K to 36.6 K (-2.96 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 10.99 | 5,000 | 54,950 | 37,725 | 32.7 K to 37.7 K (+15.28 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 50.13 | 28,500 | 1,428,705 | 28,500 | |
| Feb 26 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 39.69 | 3,325 | 131,969 | 3,325 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 38.11 | 18,300 | 697,413 | 18,300 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 7,900 | 0 | 32,725 | 24.8 K to 32.7 K (+31.82 %) |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 12.61 | 5,000 | 63,050 | 0 | |
| Aug 03 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 12.61 | 5,000 | 63,050 | 24,825 | 19.8 K to 24.8 K (+25.22 %) |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 32.02 | 4,600 | 147,292 | 4,600 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 39.69 | 13,700 | 543,753 | 13,700 | |
| Feb 05 2015 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 6,675 | 0 | 19,825 | 13.2 K to 19.8 K (+50.76 %) |
Page: 1